Design Therapeutics, Inc. (DSGN) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$9.93
Day's range
$10.43

Design Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
SR ONE CAPITAL MANAGEMENT, LP 02/12/2026 6.53 M $61.22 M   0.00% 11.46%
POINT72 ASSET MANAGEMENT, L.P. 02/17/2026 5.37 M $50.39 M   60.81% 9.43%
LOGOS GLOBAL MANAGEMENT LP 02/17/2026 2.50 M $23.45 M   -31.60% 4.39%
BAKER BROS. ADVISORS LP 02/17/2026 2.23 M $20.95 M   30.37% 3.92%
BLACKROCK, INC. 02/12/2026 2.12 M $19.86 M   3.56% 3.72%
VANGUARD GROUP INC 01/29/2026 1.63 M $15.30 M   12.97% 2.86%
VIVO CAPITAL, LLC 02/13/2026 1.61 M $15.13 M   100.00% 2.83%
ALMITAS CAPITAL LLC 02/17/2026 1.53 M $14.36 M   0.00% 2.69%
RA CAPITAL MANAGEMENT, L.P. 02/17/2026 1.46 M $13.71 M   207.21% 2.57%
DRIEHAUS CAPITAL MANAGEMENT LLC 02/17/2026 1.18 M $11.07 M   9.62% 2.07%
WOODLINE PARTNERS LP 02/17/2026 944.04 K $8.86 M   54.08% 1.66%
KYNAM CAPITAL MANAGEMENT, LP 02/17/2026 784.61 K $7.36 M   -23.79% 1.38%
FMR LLC 02/17/2026 771.27 K $7.23 M   4.11% 1.35%
MORGAN STANLEY 02/13/2026 702.31 K $6.59 M   299.06% 1.23%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 679.59 K $6.38 M   -2.30% 1.19%
STATE STREET CORP 02/13/2026 647.64 K $6.07 M   2.09% 1.14%
ACADIAN ASSET MANAGEMENT LLC 02/10/2026 612.77 K $5.74 M   -0.76% 1.08%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 02/13/2026 521.00 K $4.89 M   -73.33% 0.91%
CAPTION MANAGEMENT, LLC 02/17/2026 500.00 K $4.69 M   100.00% 0.88%
CITADEL ADVISORS LLC 02/17/2026 459.87 K $4.31 M   -16.99% 0.81%
D. E. SHAW & CO., INC. 02/17/2026 438.89 K $4.12 M   17.58% 0.77%
INVESCO LTD. 02/19/2026 305.76 K $2.87 M   1,995.81% 0.54%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 297.92 K $2.80 M   6.47% 0.52%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 287.10 K $2.69 M   4.67% 0.50%
NORTHERN TRUST CORP 02/17/2026 286.57 K $2.69 M   -3.36% 0.50%
GOLDMAN SACHS GROUP INC 03/25/2026 270.65 K $2.54 M   3.52% 0.48%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 236.86 K $2.22 M   -4.47% 0.42%
JANE STREET GROUP, LLC 02/12/2026 226.51 K $2.12 M   92.23% 0.40%
MARSHALL WACE, LLP 02/13/2026 225.53 K $2.12 M   100.00% 0.40%
02/17/2026 207.90 K $1.95 M   100.00% 0.37%
JACOBS LEVY EQUITY MANAGEMENT, INC 02/13/2026 194.61 K $1.83 M   100.00% 0.34%
ALGERT GLOBAL LLC 02/17/2026 187.77 K $1.76 M   100.00% 0.33%
MILLENNIUM MANAGEMENT LLC 02/17/2026 180.87 K $1.70 M   162.80% 0.32%
AMERIPRISE FINANCIAL INC 02/17/2026 158.38 K $1.49 M   100.00% 0.28%
ACUTA CAPITAL PARTNERS, LLC 02/17/2026 150.91 K $1.42 M   100.00% 0.27%
NUVEEN, LLC 02/12/2026 125.26 K $1.17 M   -5.84% 0.22%
RAYMOND JAMES FINANCIAL INC 02/18/2026 109.76 K $1.03 M   100.00% 0.19%
DIADEMA PARTNERS LP 02/17/2026 100.32 K $941.00 K   100.00% 0.18%
TREXQUANT INVESTMENT LP 02/17/2026 99.97 K $937.69 K   100.00% 0.18%
BNP PARIBAS ARBITRAGE, SNC 02/10/2026 94.83 K $889.49 K   1,747.42% 0.17%
BARCLAYS PLC 02/13/2026 87.06 K $816.62 K   -1.27% 0.15%
BANK OF NEW YORK MELLON CORP 02/10/2026 84.98 K $797.07 K   -2.86% 0.15%
EAM INVESTORS, LLC 02/12/2026 78.95 K $740.54 K   100.00% 0.14%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 02/17/2026 78.50 K $736.33 K   -58.29% 0.14%
LYNX1 CAPITAL MANAGEMENT LP 02/17/2026 69.52 K $652.06 K   5.40% 0.12%
PALUMBO WEALTH MANAGEMENT LLC 01/21/2026 69.38 K $650.76 K   33.21% 0.12%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 61.85 K $580.17 K   341.08% 0.11%
AMERICAN CENTURY COMPANIES INC 02/13/2026 57.80 K $542.15 K   13.66% 0.10%
CANADA PENSION PLAN INVESTMENT BOARD 02/17/2026 54.60 K $512.15 K   100.00% 0.10%
SEI INVESTMENTS CO 02/13/2026 52.73 K $494.61 K   100.00% 0.09%

Design Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 194 institutional investors and hedge funds held shares of Design Therapeutics Inc. The most heavily invested institutionals were:

DIMENSIONAL FUND ADVISORS LP: 431,840

VANGUARD FIDUCIARY TRUST CO: 195,658

Invesco Ltd.: 141,920

Nuveen, LLC: 126,815

Lynx1 Capital Management LP: 119,516

JANE STREET GROUP, LLC: 103,902

66.93% of Design Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 47.51 M shares in the last 24 months. This purchase volume represents approximately $492.65 M in transactions.